STREPTOZOCIN PLUS FLUOROURACIL VERSUS DOXORUBICIN THERAPY FOR METASTATIC CARCINOID-TUMOR

被引：203

作者：

ENGSTROM, PF

LAVIN, PT

MOERTEL, CG

FOLSCH, E

DOUGLASS, HO

机构：

[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901

[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263

[3] DANA FARBER CANC INST,BOSTON,MA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 11期

关键词：

D O I：

10.1200/JCO.1984.2.11.1255

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1255 / 1259

页数：5

共 12 条

[1]

Cox D. R., 1989, BIOMETRICS, V32, DOI DOI 10.2307/2531476

[2]

COX DR, 1972, J R STAT SOC B, V34, P18

[3]

DAVIS Z, 1973, SURG GYNECOL OBSTET, V137, P637

[4]

JOHNSON LA, 1983, CANCER-AM CANCER SOC, V51, P882, DOI 10.1002/1097-0142(19830301)51:5<882::AID-CNCR2820510522>3.0.CO

[5]

2-8

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[7]

KESSINGER A, 1977, CANCER TREAT REP, V61, P101

[8] EFFECT OF MELPHALAN IN MALIGNANT CARCINOID SYNDROME [J].

LOTITO, CA ;

MENGEL, CE .

ARCHIVES OF INTERNAL MEDICINE, 1969, 124 (01) :36-&

[9]

MENGEL CE, 1965, CANCER CHEMOTHER REP, V51, P234

[10]

Moertel C G, 1979, Cancer Clin Trials, V2, P327

← 1 2 →